Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma (Q39923530)

15 September 2017

title

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma (English)

1 reference

15 September 2017

Bing-Sheng Sun

1

1 reference

15 September 2017

Qiong-Zhu Dong

2

1 reference

15 September 2017

Qing-Hai Ye

3

1 reference

15 September 2017

Hai-Jing Sun

4

1 reference

15 September 2017

Hu-Liang Jia

5

1 reference

15 September 2017

Xiao-Qun Zhu

6

1 reference

15 September 2017

Dao-Yong Liu

7

1 reference

15 September 2017

Jie Chen

8

1 reference

15 September 2017

Qiong Xue

9

1 reference

15 September 2017

Hai-Jun Zhou

10

1 reference

15 September 2017

Ning Ren

11

1 reference

15 September 2017

Lun-Xiu Qin

12

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

48

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

1834-1842

1 reference

Global cancer statistics, 2002

15 September 2017

cites work

1 reference

Major causes of death among men and women in China

21 January 2018

1 reference

Altered wound healing in mice lacking a functional osteopontin gene (spp1).

21 January 2018

1 reference

Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty

21 January 2018

1 reference

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

21 January 2018

1 reference

The role of Osteopontin in tumor metastasis

21 January 2018

1 reference

Osteopontin: role in cell signaling and cancer progression

21 January 2018

1 reference

Increased expression of osteopontin contributes to the progression of prostate cancer

21 January 2018

1 reference

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

21 January 2018

1 reference

Improving the efficiency of RNA interference in mammals

21 January 2018

1 reference

A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells

21 January 2018

1 reference

Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics

21 January 2018

1 reference

New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis

21 January 2018

1 reference

Activation of the interferon system by short-interfering RNAs

21 January 2018

1 reference

Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells

21 January 2018

1 reference

Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.

21 January 2018

1 reference

Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

Osteopontin: regulation in tumor metastasis

21 January 2018

1 reference

Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells

21 January 2018

1 reference

Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435

21 January 2018

1 reference

Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.

21 January 2018

1 reference

Increased MAPK expression and activity in primary human hepatocellular carcinoma

21 January 2018

1 reference

Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.

21 January 2018

1 reference

NF-kappa B: ten years after

21 January 2018

1 reference

Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways

21 January 2018

1 reference

Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells

21 January 2018

1 reference

Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature

21 January 2018

1 reference

Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications

21 January 2018

1 reference

7 January 2021

The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma

1 reference

7 January 2021

High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

1 reference

7 January 2021

Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells

1 reference

7 January 2021

Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma

1 reference

7 January 2021

Overexpression of extracellular signal-regulated protein kinase and its correlation with proliferation in human hepatocellular carcinoma

1 reference

7 January 2021

Co-expression of osteopontin and CD44v9 in gastric cancer

1 reference

7 January 2021

Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22531

1 reference

15 September 2017

1 reference